S117: EVI1 DRIVES LEUKEMOGENESIS THROUGH ABERRANT ERG ACTIVATION

• J. Schmoellerl,
• I. Barbosa,
• M. Minnich,
• F. Andersch,
• L. Smeenk,
• M. Havermans,
• T. Eder,
• T. Neumann,
• J. Jude,
• M. Fellner,
• A. Ebert,
• M. Steininger,
• R. Delwel,
• F. Grebien,
• J. Zuber

Affiliations

J. Schmoellerl

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

I. Barbosa

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

M. Minnich

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

F. Andersch

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

L. Smeenk

2 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

M. Havermans

2 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

T. Eder

3 Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria

T. Neumann

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

J. Jude

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

M. Fellner

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

A. Ebert

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

M. Steininger

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria

R. Delwel

2 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

F. Grebien

3 Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria

J. Zuber

1 Research Institute of Molecular Pathology (IMP), Vienna, Austria